I'm looking for

The Latest in Gynecologic Oncology

The Society of Gynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers. As a 501(c)(6) organization, the SGO contributes to the advancement of women’s cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members and collaborating with other domestic and international organizations.

SGO publishes news releases, shares news articles relevant to the subspecialty, position statements in response to current issues in gynecologic oncology and produces special reports to shape the future of gynecologic health.

Category

Apr 1, 2020

Postsurgical Mutations Detected in Cell-Free DNA in Endometrial Cancer May Indicate Poor Prognosis

Author(s): Cancer Therapy Advisor
Categories: SGO in the News
Apr 1, 2020

Potential Predictors of Cell Transformation in Normal Fallopian Tubes of Women With a Deleterious BRCA1 Mutation

Author(s): Cancer Therapy Advisor
Categories: SGO in the News
Mar 31, 2020

Further Refining Which Subgroups of Patients With Ovarian Cancer Benefit Most From Addition of Olaparib to Maintenance Therapy With Bevacizumab

Author(s): Cancer Therapy Advisor
Categories: SGO in the News
Mar 31, 2020

Phase 3 Trial Examining ICIs in Epithelial Ovarian Cancers Halted Due to Futility

Author(s): Cancer Therapy Advisor
Categories: SGO in the News
Mar 31, 2020

More Evidence Supporting the Clinical Benefit of Niraparib Maintenance Therapy After Chemo in Advanced Ovarian Cancer

Author(s): Cancer Therapy Advisor
Categories: SGO in the News
Mar 31, 2020

Study Findings Support the Use of Video-Assisted Genetic Counseling in Ovarian Cancer

Author(s): Cancer Therapy Advisor
Categories: SGO in the News
Mar 30, 2020

Further Support for Sentinel Lymph Node Biopsy in Early-Stage Vulvar Cancer

Author(s): Cancer Therapy Advisor
Categories: SGO in the News
Mar 30, 2020

Improved OS for Patients With HER2-Positive Uterine Serous Carcinoma Receiving Trastuzumab Plus Chemotherapy

Author(s): Cancer Therapy Advisor
Categories: SGO in the News
Mar 30, 2020

Tumor Profiling Reveals Differences in Molecular Characteristics of Uterine Cancers in African-American and White Patients

Author(s): Cancer Therapy Advisor
Categories: SGO in the News
Mar 30, 2020

No OS Benefit for Addition of Metformin to Platinum-Based Therapy in Advanced Endometrial Cancer

Author(s): Cancer Therapy Advisor
Categories: SGO in the News
Mar 18, 2020

Presidential Matters: Warner Huh, MD

Author(s): SGO
Categories: Presidential Matters
Mar 9, 2020

SGO 2020 Annual Meeting Coronavirus Update

Author(s): SGO
Categories: News Releases
Feb 10, 2020

Society of Gynecologic Oncology announces 2020-2021 Board of Directors

Author(s): SGO
Categories: News Releases
Dec 20, 2019

Ovarian Cancer Community Applauds Congress for Providing $35 million Ovarian Cancer Research Funding

Author(s): SGO
Categories: News Releases
Dec 6, 2019

Presidential Matters: Warner Huh, MD

Author(s): SGO
Categories: Presidential Matters

Join SGO Today

What you get out of membership changes your patient’s lives. What you give from your membership changes the world. Join your community today.

Become a Member